SecBot SecBot
8-K ·Filed Jun 9, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001193125-26-264047
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine governance filing with no immediate trading implications. Monitor for any future executive departures or change-of-control events that would trigger the severance provisions, but no catalyst is present today.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$246.34
T+0 close · Jun 9, 2026 · via day close
Latest settled
−15.42%
T+60 · $208.35
Vs SPY
−22.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 10 $246.34entry
  2. T+1 · 5mo ago +3.02%α +1.32% · $253.77
  3. T+5 · 5mo ago +2.26%α −1.17% · $251.91
  4. T+20 · 4mo ago +1.06%α −2.56% · $248.95
  5. T+60 · 2mo ago −15.42%α −22.00% · $208.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Axsome Therapeutics adopted a formal Executive Severance and Change in Control Plan effective June 5, 2026, covering the CEO (Tier 1), other Section 16 officers (Tier 2), and VPs+ (Tier 3). The plan provides cash severance of 18/12/6 months' base salary outside a change of control, and 24/18/9 months' salary plus target bonus, full equity acceleration, and COBRA payments upon a qualifying termination during a change of control period. This is a routine adoption of a standardized severance framework that supersedes prior individual agreements, with no departure or appointment of any officer.

Key Facts

  • Plan adopted June 5, 2026, approved by Compensation Committee
  • CEO (Tier 1) gets 18 months base salary severance outside CIC, 24 months plus target bonus and full equity vesting during CIC period
  • Other Section 16 officers (Tier 2) get 12 months base salary outside CIC, 18 months plus target bonus and full equity vesting during CIC period
  • VPs+ (Tier 3) get 6 months base salary outside CIC, 9 months plus target bonus and full equity vesting during CIC period
  • Plan supersedes all prior severance arrangements in employment agreements
  • No officer departures or appointments were announced

Financial Impact

No specific dollar amounts disclosed; severance is formula-based on base salary and target bonus. The plan is unfunded and paid from general assets.

compensation expense

Risk Factors

  • No material risks identified from this filing alone

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-264047
Document: axsm-20260605.htm0001193125-26-264047
Document: 0001193125-26-264047-index-headers.html0001193125-26-264047
Document: 0001193125-26-264047-index.html0001193125-26-264047
Document: 0001193125-26-264047.txt0001193125-26-264047

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 7h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026